Vivanza Biosciences Limited

Pharmaceutical trading company with a diverse product portfolio and manufacturing facility in Gujarat.

1982 | Ahmedabad, Gujarat (India) | Active
Last Updated: July 11, 2024

Vivanza Biosciences Profile

Key Indicators

  • Authorised Capital ₹ 4.00 Cr
  • Paid Up Capital ₹ 4.00 Cr
  • Company Age 42 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 3.00 Cr
  • Revenue Growth 46.30%
  • Profit Growth 22.74%
  • Ebitda 1370.69%
  • Net Worth 14.86%
  • Total Assets 78.16%

About Vivanza Biosciences

Vivanza Biosciences Limited (VBL) is a leading Public Limited Indian Non-Government Company incorporated in India on 06 March 1982 and has a history of 42 years and 11 months. Its registered office is in Ahmedabad, Gujarat, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 530057.

The Corporate was formerly known as Ivee Injectaa Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 Cr and a paid-up capital of Rs 4.00 Cr.

The company currently has active open charges totaling ₹3.00 Cr.

The Key Managerial Personnel (KMP) at Vivanza Biosciences Limited India are Jainil Bhatt as CFO and Avinash Bhojwani as Company Secretary. Hemant Parikh, Girish Bhatt, Jayendra Mehta, and Two other members serve as directors at the Company.

Company Details

Corporate Identity Details

  • CIN/LLPIN

    L24110GJ1982PLC005057

  • Company No.

    005057

  • Stock Symbol

    BSE : 530057

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    06 Mar 1982

  • Date of AGM

    24 Jul 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Listed

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Vivanza Biosciences Limited offer?

Vivanza Biosciences Limited offers a wide range of products and services, including Scalpels, Needles & Scissors, Surgical Needles, Surgical & Medical Consumables, Surgical Disposables, Orthopedic Equipment & Supplies, Plaster Room Equipment, Bandages & Dressing Disposables, Medical Gauze, Infusion Syringes & Supplies, Medical Tubes.

Who are the key members and board of directors at Vivanza Biosciences?

Executive Team (3)

NameDesignationAppointment DateStatus
Jainil Bhatt Country flag representing In CFO17-Jun-2016Current
Jayendra Mehta Country flag representing In Managing Director25-Apr-2023Current
Avinash Bhojwani Country flag representing In Company Secretary27-May-2022Current

Board Members (4)

NameDesignationAppointment DateStatus
Hemant Parikh Country flag representing In Director 29-Mar-2019Current
Girish Bhatt Country flag representing In Director 28-Jun-2021Current
Sunil Shah Country flag representing In Director 06-Oct-2020Current
Apeksha Vyas Country flag representing In Director 25-Apr-2023Current

Financial Performance of Vivanza Biosciences.

Vivanza Biosciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.3% increase. The company also saw a substantial improvement in profitability, with a 22.74% increase in profit. The company's net worth Soared by an impressive increase of 14.86%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
46.30%
Revenue from Operations
55.31%
Total Assets
78.16%
Profit or Loss
22.74%
Net Worth
14.86%
EBITDA
1370.69%

What is the Ownership and Shareholding Structure of Vivanza Biosciences?

In 2023, Vivanza Biosciences had a promoter holding of 47.80% and a public holding of 52.21%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹3.00 Cr

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • State Bank Of India : 3.00 Cr

Latest Charge Details

DateLenderAmountStatus
10 Jan 2017State Bank Of India₹3.00 CrOpen

How Many Employees Work at Vivanza Biosciences?

Unlock and access historical data on people associated with Vivanza Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vivanza Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vivanza Biosciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Vivanza Biosciences

Recent activity within the organization

  • Annual General Meeting

    Vivanza Biosciences Limited last Annual general meeting of members was held on 24 Jul 2023 as per latest MCA records.

    24 Jul 2023

  • Director Appointment

    Jayendra Mehta was appointed as a Managing Director was appointed as a Managing Director on 25 Apr 2023 & has been associated with this company since 1 year 9 months .

    25 Apr 2023

  • Director Appointment

    Apeksha Sanjaykumar Vyas was appointed as a Director was appointed as a Director on 25 Apr 2023 & has been associated with this company since 1 year 9 months .

    25 Apr 2023

  • Balance Sheet

    Vivanza Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.

    31 Mar 2023

  • Director Appointment

    Girish Bhatt was appointed as a Director was appointed as a Director on 28 Jun 2021 & has been associated with this company since 3 years 7 months .

    28 Jun 2021

  • Director Appointment

    Sunil Devendrabhai Shah was appointed as a Director was appointed as a Director on 06 Oct 2020 & has been associated with this company since 4 years 4 months .

    06 Oct 2020

Recent News, Updates & Announcement

Frequently asked questions

  • Vivanza Biosciences Limited was incorporated on 06 Mar 1982.

  • The authorized share capital of Vivanza Biosciences Limited is ₹ 4.00 Cr and paid-up capital is ₹ 4.00 Cr.

  • Currently 7 directors are associated with Vivanza Biosciences Limited.

    • Hemant Amrish Parikh
    • Girish Bhatt
    • Jayendra Mehta
    • Sunil Devendrabhai Shah
    • Apeksha Sanjaykumar Vyas
    • Jainil Raseshkumar Bhatt
    • Avinash Govindbhai Bhojwani
  • As per Ministry of Corporate Affairs (Mca), the registered address of Vivanza Biosciences Limited is 403 Sarthik 2 Opp. Rajpath Club, S. G. Highway, Ahmedabad, Gujarat, India, 380054.

  • The corporate identification number (CIN) of Vivanza Biosciences Limited is L24110GJ1982PLC005057 and the company number is 005057 as per Ministry of Corporate Affairs (MCA).

  • Yes, Vivanza Biosciences Limited is registered on Bombay Stock Exchange (BSE).

  • The Official website of Vivanza Biosciences Limited is https://www.vivanzabiosciences.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Vivanza Biosciences Limited has risen by 46.30%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Vivanza Biosciences Limited has experienced an upsurge of 14.86%.

  • As per the financial statements for fiscal Year 2023, The total open charges for Vivanza Biosciences Limited amount to ₹ 3.00 Cr.

  • The most recent Balance Sheet for Vivanza Biosciences Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Pharmaceutical Retailers & Distributors